Jim was one of four discussants on NPR’s “On Point” and coauthor of an editorial in JAMA
![](https://www.med.unc.edu/genetics/wp-content/uploads/sites/481/2017/10/jim-evans-prominent-in-national-discussions-on-genomic-medicine-image2.jpeg)
The “On Point” discussion, related to President Obama’s announcement regarding the Precision Medicine Initiative, is available as a podcast. In the JAMA Viewpoint article, Jim and Michael Watson of the ACMG Foundation for Genetic and Genomic Medicine argue against the proposed regulation of laboratory-developed diagnostic tests by the FDA.